Apalutamide will minimize the level or outcome of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medicines that are CYP3A4 substrates may lead to decreased publicity to these prescription drugs. Diazepam can be quantified in blood https://hansq873gzn6.blogdeazar.com/profile